Eighty (80) subjects with Alcohol Use Disorder and Comorbid Major Depression, fulfilling all inclusion/exclusion criteria's will be randomly assigned to receive allogeneic human Mesenchymal stem cells or placebo in a 1:1 blinded fashion.